GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genesystem Co Ltd (XKRX:363250) » Definitions » Gross Margin %

Genesystem Co (XKRX:363250) Gross Margin % : -992.38% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Genesystem Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Genesystem Co's Gross Profit for the three months ended in Dec. 2023 was ₩-657.6 Mil. Genesystem Co's Revenue for the three months ended in Dec. 2023 was ₩66.3 Mil. Therefore, Genesystem Co's Gross Margin % for the quarter that ended in Dec. 2023 was -992.38%.


The historical rank and industry rank for Genesystem Co's Gross Margin % or its related term are showing as below:

XKRX:363250' s Gross Margin % Range Over the Past 10 Years
Min: -176.82   Med: 31.96   Max: 67.78
Current: -176.82


During the past 5 years, the highest Gross Margin % of Genesystem Co was 67.78%. The lowest was -176.82%. And the median was 31.96%.

XKRX:363250's Gross Margin % is ranked worse than
99.06% of 213 companies
in the Medical Diagnostics & Research industry
Industry Median: 46.64 vs XKRX:363250: -176.82

Genesystem Co had a gross margin of -992.38% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Genesystem Co was 0.00% per year.


Genesystem Co Gross Margin % Historical Data

The historical data trend for Genesystem Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genesystem Co Gross Margin % Chart

Genesystem Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
27.80 67.78 65.47 31.96 -176.81

Genesystem Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.23 -55.47 -190.73 -182.63 -992.38

Competitive Comparison of Genesystem Co's Gross Margin %

For the Diagnostics & Research subindustry, Genesystem Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genesystem Co's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genesystem Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Genesystem Co's Gross Margin % falls into.



Genesystem Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Genesystem Co's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=-1586.1 / 897.028
=(Revenue - Cost of Goods Sold) / Revenue
=(897.028 - 2483.108) / 897.028
=-176.81 %

Genesystem Co's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-657.6 / 66.265
=(Revenue - Cost of Goods Sold) / Revenue
=(66.265 - 723.866) / 66.265
=-992.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Genesystem Co  (XKRX:363250) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Genesystem Co had a gross margin of -992.38% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Genesystem Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of Genesystem Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genesystem Co (XKRX:363250) Business Description

Traded in Other Exchanges
N/A
Address
200-9, Techno 2-ro, Yuseong-gu, Daejeon, KOR, 34028
Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.

Genesystem Co (XKRX:363250) Headlines

No Headlines